SCHEMBL2579403

SCHEMBL2579403

Cc1c(Cc2ccc(-n3nccc3C3CC3)cc2)c(OC(F)F)nc2c(Cl)ccc(O)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2573358 0.87 PTGDR2 (0.43)
SCHEMBL2672760 0.83 PTGDR2 (0.36)
SCHEMBL2580083 0.83 GPR4 (0.32)
SCHEMBL2574521 0.82 USP1 (0.32)
SCHEMBL2579246 0.79 PTGDR2 (0.34)
SCHEMBL2573766 0.78 PTGDR2 (0.52)
SCHEMBL533987 0.77 AR (0.36)
SCHEMBL2575500 0.77 KCNH2 (0.36)
SCHEMBL2569955 0.75 PTGDR2 (0.44)
SCHEMBL3667686 0.75 PTGDR2 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139881-B1 QUINOLINES AND THEIR THERAPEUTIC USE PULMAGEN THERAPEUTICS ASTHMA LTD (GB) 2011-11-09 EP claimed
EP-2139881-A1 QUINOLINES AND THEIR THERAPEUTIC USE Argenta Oral Therapeutics Limited (GB) 2010-01-06 EP disclosed
WO-2008122784-A1 QUINOLINES AND THEIR THERAPEUTIC USE ARGENTA DISCOVERY LIMITED (GB) 2008-10-16 WO disclosed